Novo Nordisk's CagriSema Falls Short in Head to Head Trial vs Zepbound Bryce Platt, PharmD posted on the topic LinkedIn When do we choose semaglotide and when does terzipatide? EASO has just announced that it will update its algorithm with evidence until November 2025 Warning: It depends on the clinical goal. Cagrilintide 10mg Tirzepatide Australia Incretin based therapies for the treatment of obesity related diseases npj Metabolic Health and Disease MAA Semaglutide and Cagrilintide vs Tirzepatide.docx